NCT02343172View on ClinicalTrials.gov

Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

March 13, 2015

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions
Liposarcoma
Interventions
DRUG

HDM201

DRUG

LEE011

Trial Locations (9)

10002

Novartis Investigative Site, Taipei

28222

Novartis Investigative Site, Madrid

33076

Novartis Investigative Site, Bordeaux

45147

Novartis Investigative Site, Essen

69373

Novartis Investigative Site, Lyon

89081

Novartis Investigative Site, Ulm

169610

Novartis Investigative Site, Singapore

M5G 2M9

Novartis Investigative Site, Toronto

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY